Expertise in
4
conditions

Yujun J. Dong

No. 8 Xishiku Street, 
Beijing, CN 
Expertise in
4
conditions
No. 8 Xishiku Street, 
Beijing, CN 

Overview

Yujun Dong practices practicing medicine in Beijing, China.

Mr. Dong is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Light Chain Deposition Disease (LCDD), Castleman Disease, Graft Versus Host Disease (GvHD), Lymphoid Hyperplasia, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

No. 8 Xishiku Street, Beijing, 100034, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
Enrollment Status: Active_not_recruiting
Publish Date: May 15, 2026
Intervention Type: Drug
Study Drugs: LOXO-305, Ibrutinib, Acalabrutinib, Zanubrutinib
Study Phase: Phase 3
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Pirtobrutinib, Idelalisib, Bendamustine, Rituximab
Study Phase: Phase 3
A National, Prospective, Non-interventional Study of NINLARO in Real World Clinical Practice
A National, Prospective, Non-interventional Study of NINLARO in Real World Clinical Practice
Enrollment Status: Completed
Publish Date: March 04, 2026
View 2 Less Clinical Trials

72 Total Publications

Incorporation of selinexor into conditioning regimens prior to allogeneic hematopoietic stem cell transplantation: a single-center clinical study.
Incorporation of selinexor into conditioning regimens prior to allogeneic hematopoietic stem cell transplantation: a single-center clinical study.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 27, 2026

Frequently Asked Questions about Yujun J. Dong

Is Yujun J. Dong a top-rated expert for Light Chain Deposition Disease (LCDD)?

MediFind is an objective health platform that identifies experts based on real-world data. Yujun J. Dong is classified as an Advanced expert for Light Chain Deposition Disease (LCDD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yujun J. Dong participate in research or clinical trials?

Yes. Yujun J. Dong has published 72 articles and abstracts on conditions like Light Chain Deposition Disease (LCDD). You can view a list of Yujun J. Dong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dong's expertise for a condition
ConditionClose
      View All 31 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile